息性催眠方法在肌缩侧面硬化症 (ALS) 的症状治疗中
1Medical University of South Carolina, Charleston, SC, USA.
The American journal of clinical hypnosis
|November 1, 2023
概括
临床催眠对肌缩性侧面硬化症 (ALS) 患者和护理人员有好处. 这项研究探讨了催眠作为一种补充疗法,以管理ALS症状并改善生活质量.
科学领域:
- 神经学 神经学
- 抚慰性护理是一种缓解性护理.
- 补充医学是一种补充医学.
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种进展性,致命的神经退行性疾病.
- 息治疗为ALS患者和家人提供了至关重要的支持.
- 临床催眠在治疗慢性疾病症状方面表现有前途.
研究的目的:
- 审查有关ALS症状管理的催眠现有研究.
- 用临床催眠来描述ALS患者的一系列病例.
- 突出催眠在ALS的息护理中的支持作用.
主要方法:
- 在ALS支持性护理中对催眠的文献综述.
- 30名患有ALS的退伍军人接受催眠培训的案例系列.
- 对三个个别病例史的详细分析.
主要成果:
- 临床催眠和自我催眠培训被用作辅助ALS治疗.
- 具体的策略和患者对催眠的反应被记录下来.
- 有证据表明,催眠可以使ALS患者及其照顾者受益.
结论:
- 临床催眠可以成为ALS息护理的宝贵补充.
- 催眠可能有助于减轻ALS患者的症状负担.
- 需要进一步的研究来探索催眠在ALS护理中的全部潜力.
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
492
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
492
Alzheimer's Disease: Treatment
197
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
197
Parkinson's Disease: Treatment
281
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Parkinson's Disease: Overview
564
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
564
Skeletal Muscle Relaxants: Adverse Effects
376
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
376


